Exchange: NASDAQ·Updated 04:26 AM EDT
IPHA logo

IPHAInnate Pharma

$1.79
$0.0224
(1.24%)
Pre-Market
Prev Close $1.81
EarningsSep 17
Mkt Cap$169.97M
Vol261.00
Upcoming Earnings: Q2 '26

Reports: Sep 17

Estimated EPS

-$0.20

Estimated Rev

$7.53M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q2 '26
-$0.20
--
--
N/A
Q1 '26
-$0.16
--
--
N/A
Q4 '25
-$0.14
--
--
N/A
Q3 '25
-$0.14
-$0.14
--
EXPECTED
Q2 '25
--
-$0.30
--
N/A

Advertisement|Remove ads.